Daniel Zerpa

Background

About Daniel Zerpa

Pharmaceutical operations executive with 15+ years of progressive leadership across global supply chain, sterile manufacturing, engineering, finance, and enterprise strategy within GMP-regulated environments.I currently serve on the site leadership team of a sterile pharmaceutical manufacturing operation supporting approximately $2B in global commercial revenue. My scope spans end-to-end supply chain strategy, commercialization readiness, capital governance, and enterprise risk management. As of December 2025, I also provide interim executive oversight of the Engineering organization, integrating capital investment, infrastructure reliability, and capacity expansion with long-term portfolio growth strategy.My career progression reflects increasing enterprise accountability — from financial leadership within Technical Operations to leading global supply networks and serving as Interim Site Head during a period of significant market disruption.Core focus areas include:• Global end-to-end supply chain strategy• Network design and external manufacturing oversight• Commercial launch readiness and tech transfer• Capital allocation and infrastructure modernization• P&L alignment and COGS optimization• Cold chain and global trade compliance• Enterprise risk mitigation and supply continuity• Cross-functional executive alignmentI bring a unique blend of financial discipline and operational leadership, enabling me to translate strategy into execution across Manufacturing, Engineering, Supply Chain, and Finance.Open to conversations aligned with VP Supply Chain, VP Operations, and COO-track roles within complex pharmaceutical manufacturing environments.